Evidence suggests that a patient who receives more than 100mg MMEs is nine times more likely to overdose, with 12 percent of those resulting in death. Identifying at-risk patients is a first step in improving patient safety and increasing prescriber awareness. The Centers for Disease Control and Prevention (CDC) has developed and made available an opioid guideline app, which is designed to assist providers in applying the recommendations of CDC's Guidelines for Prescribing Opioids for Chronic Pain into clinical practice. This TAG contains relevant definitions, an MME conversion formula, an Excel data file for oral MMEs, a statistical analysis system (SAS) merging program, and a SAS data file for oral MMEs.
Downloads
Similar Publications
- Regioisomeric bromodimethoxy benzyl piperazines related to the designer substance 4-bromo-2,5-dimethoxybenzylpiperazine: GC–MS and FTIR analysis
 - Guide for the Selection of Personal Protective Equipment for Emergency First Responders (Percutaneous Protection-Garments); NIJ Guide 102-00, Volume IIb
 - Spatial and Temporal Assessment of Regional Crime